Yoshikawa S, Morinobu T, Hamamura K, Hirahara F, Iwamoto T, Tamai H
Department of Pediatrics, Osaka Medical College, Osaka, Japan.
Eur J Clin Nutr. 2005 Aug;59(8):900-5. doi: 10.1038/sj.ejcn.1602154.
The bioavailability of gamma-tocopherol and metabolites of vitamin E after gamma-tocopherol administration is not well understood. We investigated the effect of gamma-tocopherol administration on the levels and metabolism of alpha- and gamma-tocopherol in healthy volunteers.
We measured two metabolites of vitamin E (2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2,7,8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (gamma-CEHC)) in plasma and urine by high-performance liquid chromatography with electrochemical detection (HPLC-ECD) during administration of gamma-tocopherol. Two groups of volunteers were enrolled. The gamma-tocopherol group received two gamma-tocopherol capsules (each containing 186.4 mg of gamma-tocopherol and 5 mg of alpha-tocopherol) for 28 days, while the control group received d-alpha-tocopherol at 5 mg/day, which was the same dose as that given to the gamma-tocopherol group. Blood and urine samples were obtained on days 0, 14, 28, 35, 42, and 56 after the initiation of gamma-tocopherol administration.
The plasma gamma-tocopherol concentration increased markedly during administration of gamma-tocopherol and the plasma gamma-CEHC concentration increased along with that of gamma-tocopherol. The plasma alpha-tocopherol concentration decreased significantly during gamma-tocopherol administration. The plasma concentration of alpha-CEHC decreased significantly and urinary excretion of alpha-CEHC tended to increase in the gamma-tocopherol group. Urinary sodium secretion was significantly increased at 1 week after the cessation of gamma-tocopherol administration, but there was no significant difference of urine volume between the two groups.
Metabolism of alpha-tocopherol is accelerated and the plasma alpha-tocopherol concentration is decreased during gamma-tocopherol administration.
γ-生育酚给药后γ-生育酚及其维生素E代谢产物的生物利用度尚不清楚。我们研究了γ-生育酚给药对健康志愿者体内α-生育酚和γ-生育酚水平及代谢的影响。
在γ-生育酚给药期间,我们采用高效液相色谱电化学检测法(HPLC-ECD)测定血浆和尿液中维生素E的两种代谢产物(2,5,7,8-四甲基-2-(2'-羧乙基)-6-羟基色满(α-CEHC)和2,7,8-三甲基-2-(2'-羧乙基)-6-羟基色满(γ-CEHC))。招募了两组志愿者。γ-生育酚组连续28天服用两粒γ-生育酚胶囊(每粒含186.4 mgγ-生育酚和5 mgα-生育酚),而对照组每天服用5 mg d-α-生育酚,剂量与γ-生育酚组相同。在γ-生育酚给药开始后的第0、14、28、35、42和56天采集血液和尿液样本。
γ-生育酚给药期间血浆γ-生育酚浓度显著升高,血浆γ-CEHC浓度随γ-生育酚浓度升高而升高。γ-生育酚给药期间血浆α-生育酚浓度显著降低。γ-生育酚组血浆α-CEHC浓度显著降低,α-CEHC尿排泄量有增加趋势。γ-生育酚停药1周后尿钠分泌显著增加,但两组尿量无显著差异。
γ-生育酚给药期间α-生育酚代谢加速,血浆α-生育酚浓度降低。